ReviewFrontiers in neurology2026

Considerations for using amyloid-targeting therapies for the treatment of early symptomatic Alzheimer's disease.

Andrew E Budson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.